With Oxford Nanopore Technologies plc (LON:ONT) It Looks Like You'll Get What You Pay For
May 14
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJun 08, 2023
DataAggregated Company Financials
Companies12
- 7D-1.3%
- 3M9.6%
- 1Y-23.7%
- YTD-5.5%
Over the last 7 days, the Clinical Research and Equipment industry has risen 3.1%, driven by gains from Oxford Nanopore Technologies of 4.2%. In the past year, the industry is down 19%. Looking forward, earnings are forecast to grow by 17% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 08 Jun 2023 | UK£3.3b | UK£477.0m | -UK£117,002,400.00 | 63.5x | -28.2x | 6.9x |
| Sat, 06 May 2023 | UK£3.1b | UK£479.7m | -UK£117,045,684.00 | 36.3x | -26.9x | 6.6x |
| Mon, 03 Apr 2023 | UK£3.1b | UK£459.0m | -UK£119,153,393.00 | 34.4x | -25.7x | 6.7x |
| Wed, 01 Mar 2023 | UK£3.1b | UK£443.5m | -UK£183,041,945.00 | 42.6x | -16.7x | 6.9x |
| Fri, 27 Jan 2023 | UK£3.4b | UK£442.8m | -UK£182,605,155.00 | 45.7x | -18.4x | 7.6x |
| Sun, 25 Dec 2022 | UK£3.4b | UK£443.7m | -UK£183,037,688.00 | 49.1x | -18.4x | 7.6x |
| Tue, 22 Nov 2022 | UK£3.7b | UK£447.9m | -UK£178,884,878.00 | 50.5x | -20.7x | 8.3x |
| Thu, 20 Oct 2022 | UK£3.4b | UK£449.1m | -UK£176,522,479.00 | 43.1x | -19.5x | 7.7x |
| Sat, 17 Sep 2022 | UK£3.8b | UK£429.9m | -UK£176,728,781.00 | 44.9x | -21.4x | 8.8x |
| Mon, 15 Aug 2022 | UK£4.0b | UK£368.6m | -UK£191,199,339.00 | 49.2x | -21x | 10.9x |
| Wed, 13 Jul 2022 | UK£3.6b | UK£367.1m | -UK£188,271,852.00 | 38.7x | -19.3x | 9.9x |
| Fri, 10 Jun 2022 | UK£4.2b | UK£363.1m | -UK£189,215,004.00 | 40.6x | -22x | 11.5x |
| Sun, 08 May 2022 | UK£4.8b | UK£923.1m | -UK£165,968,602.00 | 42.5x | -28.9x | 5.2x |
| Tue, 05 Apr 2022 | UK£6.6b | UK£929.7m | -UK£311,607,727.00 | 48.8x | -21.1x | 7.1x |
| Thu, 03 Mar 2022 | UK£6.9b | UK£891.3m | -UK£199,782,907.00 | 43.5x | -34.7x | 7.8x |
| Sat, 29 Jan 2022 | UK£7.1b | UK£849.3m | -UK£186,062,933.00 | 30.4x | -38.4x | 8.4x |
| Mon, 27 Dec 2021 | UK£9.9b | UK£849.4m | -UK£186,296,285.00 | 30.6x | -52.9x | 11.6x |
| Wed, 24 Nov 2021 | UK£9.0b | UK£844.0m | -UK£190,370,545.00 | 20.2x | -47.4x | 10.7x |
| Fri, 22 Oct 2021 | UK£7.5b | UK£819.7m | -UK£187,962,744.00 | 26.7x | -39.8x | 9.1x |
| Sun, 19 Sep 2021 | UK£3.0b | UK£674.8m | -UK£137,210,769.00 | 27x | -22.2x | 4.5x |
| Tue, 17 Aug 2021 | UK£2.9b | UK£670.4m | -UK£160,499,800.35 | 64.1x | -18.4x | 4.4x |
| Tue, 01 Jun 2021 | UK£3.6b | UK£670.8m | -UK£88,500,847.08 | 74.8x | -40.4x | 5.3x |
| Fri, 05 Mar 2021 | UK£3.4b | UK£671.0m | -UK£14,663,770.60 | 73.6x | -231.1x | 5.1x |
| Mon, 07 Dec 2020 | UK£2.7b | UK£652.1m | UK£165.1m | 58.6x | 16.2x | 4.1x |
| Thu, 10 Sep 2020 | UK£2.5b | UK£632.0m | UK£378.8m | 48.5x | 6.5x | 3.9x |
Price to Earnings Ratio
6.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.9x is higher than the industry's current PS ratio of 7.0x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 9.0% per year, which is driving profits down.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 2.27% | |
| Healthcare | 1.22% | |
| Life Sciences | -1.29% | |
| Clinical Research and Equipment | -1.29% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MXCT MaxCyte | UK£3.50 | 5.3% +UK£18.0m | -5.4% | PS10.9x | |
| DXRX Diaceutics | UK£0.89 | 9.3% +UK£6.3m | -17.7% | PE103x | |
| PRM Proteome Sciences | UK£0.05 | 5.0% +UK£693.7k | 32.7% | PE11.1x | |
| C4XD C4X Discovery Holdings | UK£0.16 | 1.1% +UK£441.2k | -38.7% | PS9.5x | |
| OBD Oxford BioDynamics | UK£0.14 | 1.3% +UK£256.7k | -25.2% | PB3x |
